SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
The association between prescribed hormonal contraception and multiple sclerosis risk: a systematic review and meta-analysis.
Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSex hormones can influence susceptibility to multiple sclerosis (MS). Around 400 million women worldwide use hormonal contraceptives (HC), which contain synthetic versions of female sex hormones. Evidence on HC use and MS risk is inconclusive. The aim of this study was to synthesise studies on the association between prescribed HC and the risk of MS.
methodsMedline, Embase, Cochrane library and grey literature were systematically searched on 7th November 2024. Two reviewers independently screened, extracted data and appraised each study's quality using the Joanna Briggs Institute critical appraisal tool. Pre-determined criteria were used to differentiate between high- and low-quality studies. Random-effects meta-analysis was conducted for studies providing the same effect measure; heterogeneity was assessed. Sensitivity analyses included only high-quality studies.
resultsEleven studies were included, six of these were cohort and five were case-control. Three studies were deemed high-quality. Five of the studies found no significant association between HC use and MS risk, four found a decreased risk, and two found an increased risk. Meta-analysis of the unadjusted odds ratio (OR) showed a significantly increased risk of MS with HC use of 1.28 (95% CI 1.08-1.52). However meta-analysis of adjusted ORs and sensitivity analyses showed no significant association. Heterogeneity was high.
conclusionNo statistically significant association between HC use and MS risk was observed. The meta-analyses indicate a possible increased risk warranting further investigation. Given that heterogeneity was high and only three of the included studies were classed as high-quality, a well-designed study is needed to clarify this association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.